Skybiotech Healthcare Limited (BOM:512036)
India
· Delayed Price · Currency is INR 138.90
0.00 (0.00%)
At close: Apr 17, 2026
Skybiotech Healthcare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | -2.69 | 84.33 | 0.17 | 0.12 | 0.18 | Upgrade
|
| Cash & Short-Term Investments | - | -2.69 | 84.33 | 0.17 | 0.12 | 0.18 | Upgrade
|
| Cash Growth | - | - | 48132.08% | 49.45% | -33.85% | 57.78% | Upgrade
|
| Accounts Receivable | - | 4.25 | 0 | - | - | 0.01 | Upgrade
|
| Receivables | - | 4.25 | 0 | - | - | 0.01 | Upgrade
|
| Inventory | - | 15.94 | - | - | - | - | Upgrade
|
| Prepaid Expenses | - | 0.01 | - | - | - | - | Upgrade
|
| Other Current Assets | - | 1.67 | 1.63 | 0.03 | 0.04 | - | Upgrade
|
| Total Current Assets | - | 19.18 | 85.96 | 0.21 | 0.16 | 0.19 | Upgrade
|
| Property, Plant & Equipment | - | 88.44 | 0.05 | 0.06 | 0.07 | 0.09 | Upgrade
|
| Long-Term Investments | - | 24.65 | 25.87 | 36.97 | 40.1 | 33.32 | Upgrade
|
| Goodwill | - | 31.31 | - | - | - | - | Upgrade
|
| Other Intangible Assets | - | 0.52 | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | - | 9.23 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | - | 27.67 | 3.38 | 3.38 | 3.38 | 3.38 | Upgrade
|
| Total Assets | - | 200.98 | 115.26 | 40.62 | 43.71 | 36.99 | Upgrade
|
| Accounts Payable | - | 6.23 | - | - | - | - | Upgrade
|
| Accrued Expenses | - | 2.07 | 0.2 | 0.04 | 0.06 | 0.07 | Upgrade
|
| Short-Term Debt | - | 1.9 | - | - | - | - | Upgrade
|
| Current Income Taxes Payable | - | 0.16 | 3.39 | - | - | - | Upgrade
|
| Other Current Liabilities | - | 15.16 | 0.44 | - | - | - | Upgrade
|
| Total Current Liabilities | - | 25.53 | 4.07 | 0.07 | 0.08 | 0.09 | Upgrade
|
| Long-Term Debt | - | 70.08 | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 2.87 | 5.65 | 6.43 | 4.74 | Upgrade
|
| Other Long-Term Liabilities | - | -0 | 0 | - | - | 0 | Upgrade
|
| Total Liabilities | - | 95.61 | 6.94 | 5.72 | 6.52 | 4.83 | Upgrade
|
| Common Stock | - | 19.15 | 19.15 | 10.4 | 10.4 | 10.4 | Upgrade
|
| Additional Paid-In Capital | - | - | 58.04 | 5.54 | 5.54 | 5.54 | Upgrade
|
| Retained Earnings | - | - | 15.85 | 0.5 | 0.57 | 0.95 | Upgrade
|
| Comprehensive Income & Other | - | 70.72 | 15.28 | 18.46 | 20.68 | 15.27 | Upgrade
|
| Total Common Equity | - | 89.87 | 108.32 | 34.9 | 37.2 | 32.16 | Upgrade
|
| Minority Interest | - | 15.5 | - | - | - | - | Upgrade
|
| Shareholders' Equity | - | 105.37 | 108.32 | 34.9 | 37.2 | 32.16 | Upgrade
|
| Total Liabilities & Equity | - | 200.98 | 115.26 | 40.62 | 43.71 | 36.99 | Upgrade
|
| Total Debt | - | 71.98 | - | - | - | - | Upgrade
|
| Net Cash (Debt) | - | -74.67 | 84.33 | 0.17 | 0.12 | 0.18 | Upgrade
|
| Net Cash Growth | - | - | 48132.08% | 49.45% | -33.85% | 57.78% | Upgrade
|
| Net Cash Per Share | - | -38.99 | 44.04 | 0.17 | 0.11 | 0.17 | Upgrade
|
| Filing Date Shares Outstanding | - | 1.92 | 1.92 | 1.04 | 1.04 | 1.04 | Upgrade
|
| Total Common Shares Outstanding | - | 1.92 | 1.92 | 1.04 | 1.04 | 1.04 | Upgrade
|
| Working Capital | - | -6.35 | 81.89 | 0.13 | 0.08 | 0.1 | Upgrade
|
| Book Value Per Share | - | 46.93 | 56.56 | 33.55 | 35.76 | 30.92 | Upgrade
|
| Tangible Book Value | - | 58.05 | 108.32 | 34.9 | 37.2 | 32.16 | Upgrade
|
| Tangible Book Value Per Share | - | 30.31 | 56.56 | 33.55 | 35.76 | 30.92 | Upgrade
|
| Land | - | 25.31 | - | - | - | - | Upgrade
|
| Buildings | - | 85.14 | - | - | - | - | Upgrade
|
| Machinery | - | 68.16 | 0.52 | 0.52 | 0.52 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.